1422 ET -- Johnson & Johnson and Merck & Co. are two of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. J&J will acquire Ambrx Biopharma in a deal with a total equity value of about $2 billion. Merck agreed to buy Harpoon Therapeutics for about $680 million. In both transactions, the per-share deal value is more than twice the Friday closing price. Dow Jones & Co. owns Factiva. (josh.beckerman@wsj.com)

(END) Dow Jones Newswires

January 08, 2024 14:39 ET (19:39 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.
Ambrx Biopharma (NASDAQ:AMAM)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Ambrx Biopharma 차트를 더 보려면 여기를 클릭.
Ambrx Biopharma (NASDAQ:AMAM)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Ambrx Biopharma 차트를 더 보려면 여기를 클릭.